PMID: 3319543Jan 1, 1987Paper

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

Epilepsia
D B SmithB Craft

Abstract

In 1985 a 5-year multicenter Veterans Administration Cooperative Study was completed that compared the efficacy and toxicity of phenobarbital, carbamazepine, phenytoin, and primidone in a double-blind prospective study design. A total of 622 patients, either previously untreated or undertreated, were entered into the study. Strict exclusion criteria limited confounding factors such as drug or alcohol abuse. Results showed that each of the four drugs used as monotherapy were similarly effective in the treatment of generalized tonic clonic seizures, but carbamazepine was significantly more effective in the treatment of complex partial seizures as measured by 100% control. When the results for all four drugs were combined, the data showed that approximately 80% of the patients were adequately managed on monotherapy. Differences in toxicity were the most significant factor that discriminated between these four drugs. Both carbamazepine and phenytoin were associated with significantly lower incidences of intolerable side effects than were primidone or phenobarbital. A behavioral toxicity battery was performed whenever possible prior to administration of any antiepileptic drug and at 1, 3, 6, and 12 months after initiation of monothe...Continue Reading

References

Jul 1, 1976·The Journal of Nervous and Mental Disease·E A RodinP M Rennick
Jan 1, 1975·Acta Neurologica Scandinavica. Supplementum·A S TroupinL M Halpern
Dec 1, 1975·Clinical Pharmacology and Therapeutics·J J CereghinoB G White
Sep 1, 1975·The Journal of Nervous and Mental Disease·C B Dodrill, A S Troupin
May 1, 1974·Neurology·J J CereghinoB G White
May 20, 1968·JAMA : the Journal of the American Medical Association·J G Milichap, F Aymat
Feb 1, 1971·Journal of Consulting and Clinical Psychology·M Lorr, R M Hamlin
Jan 1, 1966·Archives of Neurology·P T WhiteJ Norton
Mar 1, 1983·Neurology·A V Delgado EscuetaJ F Collins
Oct 1, 1982·Epilepsia·P J Thompson, M R Trimble
Dec 1, 1951·Journal of the American Medical Association·E R IVES
Jan 13, 2006·Neurology·H Richard BeresfordMurray G Sagsveen

❮ Previous
Next ❯

Citations

Apr 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B P Hermann
Nov 1, 1995·Pharmacology, Biochemistry, and Behavior·A BeckerM Brosz
May 1, 1995·Progress in Neuro-psychopharmacology & Biological Psychiatry·L G NeyensA P Aldenkamp
Jan 1, 1991·Epilepsy Research·G C PalmerE A Swinyard
Mar 18, 2004·Research in Developmental Disabilities·Johnny L MatsonStephen B Mayville
Dec 5, 2003·Epilepsy & Behavior : E&B·Andres M Kanner
Jan 17, 2004·Epilepsy & Behavior : E&B·Pavel Ortinski, Kimford J Meador
Jan 17, 2004·Epilepsy & Behavior : E&B·Rianne ReijsMarc De Krom
Jul 27, 1999·Pharmacology, Biochemistry, and Behavior·M K BanksP E Garraghty
May 24, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·M K BanksP E Garraghty
Apr 12, 2002·Epilepsy Research·Laura Marsh, Vani Rao
Mar 1, 1993·Seizure : the Journal of the British Epilepsy Association·N P VermaM F Greiffenstein
Jun 1, 1995·Seizure : the Journal of the British Epilepsy Association·A P Aldenkamp, J Vermeulen
Jan 15, 1999·Seizure : the Journal of the British Epilepsy Association·M Baldy-MoulinierE Perucca
Jul 31, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Yoshinobu GotoShozo Tobimatsu
Mar 1, 2003·Epilepsy & Behavior : E&B·Dalma Kalogjera-Sackellares, J Chris Sackellares
Sep 27, 2003·Epilepsia·Ettore Beghi
Sep 11, 2012·Brain : a Journal of Neurology·Niels EijkelkampJohn N Wood
Feb 1, 1993·Journal of Clinical Pharmacy and Therapeutics·R Ismail, A F Rahman
Sep 1, 1994·Epilepsia·C HelmstaedterM Lendt
Apr 2, 2011·Epilepsia·Gus A BakerUNKNOWN SANAD group
Jan 1, 1992·Acta Neurologica Scandinavica. Supplementum·A P AldenkampA M Beun
Jan 1, 1992·Acta Neurologica Scandinavica. Supplementum·M M Robertson
Sep 1, 1992·Acta Neurologica Scandinavica·A TartaraE Perucca
Mar 24, 1998·Annual Review of Medicine·C W Bazil, T A Pedley
Mar 20, 2002·Pharmacotherapy·Thomas E Lackner
Jan 1, 2008·Annals of Indian Academy of Neurology·Chhaya ValviMadhuri Agarwal
Mar 2, 1999·Therapeutic Drug Monitoring·J C DeToledoR E Ramsay
May 31, 2011·Expert Opinion on Drug Safety·Sherifa Ahmad Hamed
May 21, 2011·Epilepsy & Behavior : E&B·Erik D RobersonDieter Schmidt
Jun 11, 2008·Epilepsy Research·Michael J McLeanDaniel Polley
Aug 21, 2007·Clinical Neurology and Neurosurgery·Rishi V A Sheorajpanday, Peter P De Deyn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.